Kangmei Pharmaceutical Market Cap

Kangmei Pharmaceutical has a market cap or net worth of 29.46 billion as of November 14, 2025. Its market cap has increased by 16.74% in one year.

Market Cap

29.46B

Enterprise Value

28.43B

Revenue

5.28B

Ranking

n/a

PE Ratio

1,770.12

Stock Price

2.11

Market Cap Chart

Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 29.46B, an increase of 1,042.34%. That is a compound annual growth rate of 10.38%.

Market Cap History

Date	Market Cap	% Change
Nov 14, 2025	29.46B	-9.20%
Dec 31, 2024	32.44B	25.81%
Dec 29, 2023	25.79B	-15.45%
Dec 30, 2022	30.50B	-28.80%
Dec 31, 2021	42.84B	221.38%
Dec 31, 2020	13.33B	-28.15%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Pharmaceuticals Co.,Ltd	417.34B
WuXi AppTec	282.16B
Shenzhen Mindray Bio-Medical Electronics	251.19B
Sichuan Biokin Pharmaceutical	153.43B
Aier Eye Hospital Group	113.87B
Shanghai United Imaging Healthcare	112.24B
Zhangzhou Pientzehuang Pharmaceutical.,	109.07B
Yunnan Baiyao Group Co.,Ltd	101.10B

Market Cap Rankings